Safety and efficacy data comparing patients with basilar artery occlusion and patients with large vessel occlusion in the anterior circulation
MT of BAO (n=165) | MT of ACLVO (n=1574) | P value | |
Efficacy | |||
mTICI 3 | 102/165 (61.8%) | 706/1571 (44.9%) | <0.001 |
mTICI ≥2b | 149/165 (90.3%) | 1299/1571 (82.7%) | 0.011 |
Time from groin puncture to recanalization (min) | 45 (30–81), N=153 | 47 (30–75), N=1471 | 0.824 |
General anesthesia | 142/161 (88.2%) | 792/1442 (54.9%) | <0.001 |
Additional intra-arterial thrombolytic agents | 18/160 (11.3%) | 112/1443 (7.8%) | 0.127 |
Maneuver count | 1 (IQR 1–2), N=101 | 2 (1–3), N=1106 | 0.002 |
Intracranial stenting | 28/165 (17.0%) | 36/1572 (2.3%) | <0.001 |
Extracranial stenting | 13/165 (7.9%) | 182/1572 (11.6%) | 0.194 |
Safety | |||
sICH ECASS II definition | 8/165 (4.8%) | 98/1562 (6.3%) | 0.608 |
Systemic bleeding | 1/39 (2.6%) | 21/637 (3.3%) | 1.000 |
Craniectomy | 4/161 (2.5%) | 51/1448 (3.5%) | 0.649 |
Any interventional complication | 18/165 (10.9%) | 198/1572 (12.6%) | 0.620 |
Complications |
|
|
ACLVO, anterior circulation large vessel occlusion; BAO, basilar artery occlusion; MT, mechanical thrombectomy; mTICI, modified Thrombolysis in Cerebral Infarction; sICH, symptomatic intracranial hemorrhage according to the European Cooperative Acute Stroke Study II definition.Difference in numbers of observations and total numbers of patients in each group due to missing data items.